Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 3 of 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Vascular cognitive impairment risk among Mongolian adults: An overview
    Cognitive impairment is commonly associated with older people. It can also occur in middle-aged people due to non-communicable diseases. The prevalence of lifestyle-related diseases (non-communicable diseases) has been rapidly increasing in Mongolia. Therefore, we aimed to overview these studies to identify whether the increasing prevalence of non-communicable disease is associated with the risks of cognitive impairment in Mongolians. Published literature between 01 January 1980 and 20 June 2021 were included in the study. We searched articles published in journals registered to PubMed and doctoral and master's dissertations registered in the Central Medical Library of Mongolia using the following keywords: "cognitive impairment", "dementia", "mild cognitive impairment", "Alzheimer", "vascular dementia", “diabetes", "Mongolia", "obesity", "stroke", "hypertension". While there were no internationally published articles in this field, seven studies were either published in local research journals or as doctoral or master’s dissertations. Although few studies have been conducted in Mongolia, people with lifestyle-related conditions such as hypertension and diabetes are strongly associated with a higher risk of cognitive impairment. The increasing prevalence of non-communicable diseases may be one of the factors contributing to the prevalence of vascular cognitive impairment.
    Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Blood Pressure Levels and Triglyceride-Glucose Index: A Cross-Sectional Study from a Nationwide Screening in Mongolia
    (2025-09) ;
    Enebish, Oyunsuren
    ;
    ; ;
    Gantulga, Munkhtulga
    Background: The triglyceride-glucose (TyG) index has emerged as a reliable surrogate marker of insulin resistance. This study aimed to investigate the association between blood pressure (BP) levels and the TyG index and to assess whether even modest elevations in BP were associated with higher TyG index values. Methods: A cross-sectional analysis was conducted using data from 120,264 participants who underwent nationwide health screening in Mongolia between 2023 and 2024. BP was categorized into five stages. The TyG index was calculated based on fasting triglyceride and glucose levels. Results: The mean TyG index increased progressively with advancing hypertension stages (p for trend <0.001). Multivariate analysis showed that even elevated BP was independently associated with a higher TyG index (adjusted OR 1.108, 95% CI 1.039-1.183; p = 0.002), with the association strengthening across hypertension stage 1 (adjusted OR 1.238, 95% CI 1.200-1.277), stage 2 (adjusted OR 1.516, 95% CI 1.463-1.572), and hypertensive crisis (adjusted OR 1.575, 95% CI 1.350-1.836) (all p < 0.001). Central obesity further amplified the association between hypertension stage and TyG index levels. Among participants without central obesity, the TyG index increased from 8.086 (95% CI: 8.079-8.093) in the normal BP group to 8.449 (8.362-8.536) in the hypertensive crisis group. Similarly, among those with central obesity, the TyG index rose from 8.345 (8.336-8.354) in the normal group to 8.732 (8.685-8.778) in the hypertensive crisis group. Conclusions: This study demonstrates that the TyG index rises consistently with increasing BP stages, even at early elevations, suggesting that insulin resistance may begin at modest blood pressure increases.
    Scopus© Citations 2